Table 4.
Clinical and laboratory markers of autoimmunity in patients affected by BSS
| Autoimmune markers | Autoimmune disease | |
|---|---|---|
| BSS1 | Anti-dsDNA indeterminated, RF | Rheumatoid arthritis |
| BSS2 | – | – |
| BSS3 | – | – |
| BSS4 | – | – |
| BSS5 | TG-Ab | Hashimoto’s thyroiditis |
| BSS6 | – | – |
| BSS7 | TG-Ab, TPO-Ab | Hashimoto’s thyroiditis, vitiligo, Sjögren’s syndrome |
| BSS8 | – | – |
| BSS9 | ANA (1:160) | – |
| BSS10 | DAT+ | – |
| BSS11 | ANA (1:160) | – |
| BSS12 | DAT+, ENA (Anti Ro52Ab), ANA (1:160) | – |
| BSS13 | APCA, ANA (1:160), GAD-Ab | – |
Abbreviations: Anti-dsDNA anti-double stranded DNA, RF rheumatoid factor, TG-Ab thyroglobulin antibody, TPO-Ab thyroid peroxidase antibody, ANA anti-nuclear antibody, DAT Direct Antiglobulin Test, APCA anti-parietal cell antibody, GAD-Ab Glutamic Acid Decarboxylase autoantibodies; −, absent